Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion

JM Delfs, Y Zhu, JP Druhan, G Aston-Jones - Nature, 2000 - nature.com
JM Delfs, Y Zhu, JP Druhan, G Aston-Jones
Nature, 2000nature.com
Cessation of drug use in chronic opiate abusers produces a severe withdrawal syndrome
that is highly aversive, and avoidance of withdrawal or associated stimuli is a major factor
contributing to opiate abuse,. Increased noradrenaline in the brain has long been implicated
in opiate withdrawal, but it has not been clear which noradrenergic systems are involved.
Here we show that microinjection of β-noradrenergic-receptor antagonists, or of an α2-
receptor agonist, into the bed nucleus of the stria terminalis (BNST) in rats markedly …
Abstract
Cessation of drug use in chronic opiate abusers produces a severe withdrawal syndrome that is highly aversive, and avoidance of withdrawal or associated stimuli is a major factor contributing to opiate abuse,. Increased noradrenaline in the brain has long been implicated in opiate withdrawal, but it has not been clear which noradrenergic systems are involved. Here we show that microinjection of β-noradrenergic-receptor antagonists, or of an α2-receptor agonist, into the bed nucleus of the stria terminalis (BNST) in rats markedly attenuates opiate-withdrawal-induced conditioned place aversion. Immunohistochemical studies revealed that numerous BNST-projecting cells in the A1 and A2 noradrenergic cell groups of the caudal medulla were activated during withdrawal. Lesion of these ascending medullary projections also greatly reduced opiate-withdrawal-induced place aversion, whereas lesion of locus coeruleus noradrenergic projections had no effect on opiate-withdrawal behaviour. We conclude that noradrenergic inputs to the BNST from the caudal medulla are critically involved in the aversiveness of opiate withdrawal.
nature.com